ALBANY MOLECULAR RESEARCH INC. (AMRI) (Now Curia Global)
History
| Year | Detail |
|---|---|
| 1991 | Thomas E. D'Ambra Co-founded Albany Molecular Research Inc. |
| 2007 | Albany Molecular Research Inc. company changed its name to AMRI. |
| 2014 | Acquired Cedarburg Pharmaceuticals Inc. compnay that develops and manufactures complex APIs including controlled substances and steroids and Oso BioPharmaceuticals Manufacturing company, a premier contract manufacturer of complex injectable drug products. |
| 2015 | AMRI Acquired Gadea Pharmaceutical Group and Whitehouse Laboratories and Launched integrated drug discovery center in Buffalo, New York., in partnership with New York State as a founding member of the Buffalo Medical Innovation and Commercialization Hub. |
| 2016 | The compnay acquired Prime European Therapeuticals S.p.A., also known as Euticals, headquartered in Lodi, Italy. Euticals' custom synthesis and API manufacturing capabilities broadens AMRI's custom synthesis offerings in key European markets. |
| 2021 | AMRI relaunches as Curia. The new name reinforces the company's strategic positioning as an end-to- end global CDMO, enabling biopharmaceutical customers to advance important new products that improve lives. |
BCC Research Beacon 